Article
Novel Markers of Subclinical Disease for Ewing Family Tumors from Gene Expression Profiling
1 Dec 2007
Abstract excerpt
PURPOSE: Targeting subclinical disease in the bone marrow is particularly relevant in metastatic Ewing family tumors (EFT) where cure is difficult. Genome-wide expression arrays can uncover novel genes differentially expressed in tumors over normal marrow/blood, which may have potentials as markers of subclinical disease. EXPERIMENTAL DESIGN: Gene expression array data were obtained on 28 EFT tumors using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
